• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Crucell ADR

Crucell ADR

  1. All
  2. 3rd Party
  3. Investing
  1. Specialty Vaccine Company PaxVax Secures Up to $60 Million in Financing

    Specialty Vaccine Company PaxVax Secures Up to $60 Million in Financing

  2. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  3. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.